Eagle Pharmaceuticals (NASDAQ:EGRX) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a report released on Friday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Down 1.4 % Shares of EGRX stock opened at $4.09 on Friday. Eagle Pharmaceuticals has a 52-week low of $3.21 and a […]
More Stories
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Plus Therapeutics (NASDAQ:PSTV) Financial Comparison
Plus Therapeutics (NASDAQ:PSTV – Get Free Report) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINN – Get Free Report) are both small-cap...
Massimo Group (NASDAQ:MAMO) Trading Up 4% – What’s Next?
Shares of Massimo Group (NASDAQ:MAMO – Get Free Report) were up 4% on Wednesday . The company traded as high...
AlTi Global (NASDAQ:ALTI) Share Price Crosses Above 200-Day Moving Average – What’s Next?
AlTi Global, Inc. (NASDAQ:ALTI – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday...
AVEVA Group (LON:AVV) Shares Cross Above 200-Day Moving Average – Here’s What Happened
AVEVA Group plc (LON:AVV – Get Free Report)’s share price crossed above its two hundred day moving average during trading...
Culp (NYSE:CULP) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?
Culp, Inc. (NYSE:CULP – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The...
THG Plc (OTCMKTS:THGPF) Short Interest Update
THG Plc (OTCMKTS:THGPF – Get Free Report) was the target of a significant increase in short interest in October. As...